Low-dose gemcitabine plus nab-paclitaxel versus standard-dose gemcitabine plus nab-paclitaxel in elderly patients with metastatic pancreatic cancer: A randomized Phase II trial.
Mamoru TakenakaHajime ImaiHisakazu MatsumotoYukitaka YamashitaTakao KatoKatsuhisa NishiShunsuke OmotoKosuke MinagaKentaro YamaoTomoko HyodoSung-Woon ImAkane HaraTomoe YoshikawaRei IshikawaAyana OkamotoTomohiro YamazakiAtsushi NakaiKazuomi UeshimaYasutaka ChibaMamoru TakenakaTomohiro WatanabeMasayuki KitanoMasatoshi KudoPublished in: JGH open : an open access journal of gastroenterology and hepatology (2023)
Low-dose GnP had an equivalent efficacy to conventional therapy; however, it did not reduce adverse events.